Company news: CSL Behring and McGraw-Hill
McGraw-Hill launched mobile versions of its AccessMedicine and AccessPharmacy sites for healthcare professionals. The publisher currently supports iPhone and iPhone 3G, Android and BlackBerry Bold.
ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.
The FDA greenlighted the drug for three cancers.
A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.